Cenra Inc. (TPE:3716)
Taiwan · Delayed Price · Currency is TWD 32.30
+0.10 (0.31%)
At close: Apr 24, 2026
Cenra Market Cap
Cenra has a market cap or net worth of 4.72 billion as of April 24, 2026. Its market cap has decreased by -15.02% in one year.
Market Cap
4.72B
Enterprise Value
7.02B
Revenue
8.57B
Ranking
n/a
PE Ratio
13.57
Stock Price
32.30
Market Cap Chart
Since September 2, 2024, Cenra's market cap has decreased from 6.21B to 4.72B, a decrease of -23.93%. That is a compound annual growth rate of -15.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 4.72B | -3.34% |
| Dec 31, 2025 | 4.88B | -12.15% |
| Dec 31, 2024 | 5.56B | -10.42% |
| Sep 2, 2024 | 6.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 230.12B |
| Caliway Biopharmaceuticals | 155.17B |
| Heron Neutron Medical | 60.80B |
| Lotus Pharmaceutical | 58.87B |
| UnicoCell Biomed | 5.14B |
| Easywell Biomedicals | 5.02B |
| Pharmosa Biopharm | 4.88B |
| SciVision Biotech | 4.56B |